Vanguard Group Inc Scynexis Inc Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Scynexis Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,686,967 shares of SCYX stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,686,967
Previous 1,687,670
0.04%
Holding current value
$1.7 Million
Previous $3.38 Million
25.54%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SCYX
# of Institutions
48Shares Held
13.7MCall Options Held
21.9KPut Options Held
2.6K-
Federated Hermes, Inc. Pittsburgh, PA3.6MShares$3.63 Million0.01% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$2.26 Million0.4% of portfolio
-
Avidity Partners Management LP Dallas, TX1.45MShares$1.46 Million0.13% of portfolio
-
Amh Equity LTD600KShares$606,0001.24% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$561,1100.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $33M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...